9 hours ago
A potential new treatment for #lupus, RC18 (telitacicept), has shown promising results in a Phase 2b trial when combined with other lupus medication.“These data show the promise of RC18 to precisely target lupus with its novel dual-target mechanism and become a first-in-class and best-in-class treatment,” ... See MoreSee Less
Add-on RC18 Reduced Disease Activity, Well-Tolerated by SLE Patients, Phase 2b Trail Shows
Please click on the link below to visit our Eclipse Light Sensitivity Support Group.
Here you will find practical advice and information on managing light sensitivity.
GO TO ECLIPSE
St James House
Essex RM1 3NH
United Kingdom(00 44) (0)1708 731251Email Us
Information for medical professionals
©2015 LUPUS UK (Registered charity nos. 1051610, SC039682)
Website managed by Ghost Enterprises